
Mikastar 250mg Injection
Marketer
Mankind Pharma Ltd
Salt Composition
Amikacin (250mg)
Overview Mikastar 250mg Injection
Cefamandole 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary system, skeletal system, respiratory system (like pneumonia), central nervous system, and circulatory system. Prophylactic use is also common in hospitalized individuals. This antibiotic functions by inhibiting bacterial proliferation. Administration, either intravenously or intramuscularly, must be overseen by a medical professional; self-injection is strictly prohibited. Adherence to the prescribed dosage schedule, at regular intervals, is crucial. Premature discontinuation risks relapse or infection exacerbation. Typical side effects involve injection site inflammation and elevated blood urea nitrogen. Persistent adverse effects or treatment ineffectiveness necessitate immediate medical consultation. High doses may lead to vertigo, nephrotoxicity, and ototoxicity. Therefore, strict adherence to physician instructions is mandatory, including potential monitoring via renal function, audiometric, and urinalysis assessments. Pregnancy contraindicates the use of this medication. Disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Primary Ingredients of Mikastar 250mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Mikastar 250mg Injection
Infections caused by bacteria
Major Benefits of Mikastar 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Mikastar 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikastar 250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Mikastar 250mg Injection works:
Mikastar 250mg Injection is a bacterial growth inhibitor, a type of antibiotic that works by disrupting the production of vital bacterial proteins.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Mikastar 250mg Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Mikastar 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Mikastar 250mg Injection pose minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no known harm to infants.
DrivingUNSAFE
Administering Mikastar 250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should use Mikastar 250mg Injection cautiously. The Mikastar 250mg Injection dosage might require modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mikastar 250mg Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary for this patient population. Physician consultation is advised.
What if you forget to take Mikastar 250mg Injection :
Should you forget a scheduled dose of Mikastar 250mg Injection, seek medical advice.
Facts to Know About Mikastar 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
